Skip to main content
Table of Contents
Print

Are There Dangerous Interactions Between Cannabis and Antidepressants When Used for Mood Disorders? 

Author: Dr. Clarissa Morton, PharmD

The question of cannabis and drug interactions is an important one for patients using antidepressants alongside cannabis. For individuals with mood disorders , combining cannabinoids with prescribed medication may alter how drugs are metabolised, affecting both safety and effectiveness. Patients with a mental health condition such as depression or anxiety must be especially cautious, as improper combinations could worsen symptoms or increase side effects. 

While some patients report no problems, others may experience dizziness, sleepiness, or unexpected mood changes when cannabis is combined with antidepressants. 

Cannabis And Antidepressant Interactions 

Understanding the scope of cannabis and drug interactions involves exploring how cannabinoids affect different classes of antidepressants. The following points highlight where risks are most often identified. 

Cannabis Interactions 

Some evidence suggests cannabis and antidepressant interactions can influence serotonin levels, potentially intensifying or dampening medication effects depending on the type of antidepressant. 

MAOI, SSRI, And Cannabis 

The relationship between MAOI, SSRI, and cannabis is particularly complex. Cannabis may interfere with these drugs’ metabolism, raising the risk of side effects such as agitation, sedation, or blood pressure changes. 

Medication Interactions with Cannabinoids 

Broader medication interactions with cannabinoids include liver enzyme interference, which can affect how drugs are processed in the body, leading to higher or lower than expected medication levels. 

In summary, while cannabis may provide relief for some, the risks of cannabis and drug interactions should not be overlooked. Careful medical guidance is essential when combining cannabis with antidepressants. 

For patients considering cannabis alongside antidepressant treatment, providers like LeafEase can offer expert consultations tailored to safe and informed use. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories